RCUS Arcus Biosciences, Inc.
Arcus Biosciences, Inc. (RCUS) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
How much of that selling was preplanned? 79% planned / 21% discretionary
Largest single sale: $2.1M.
Where they traded
No open-market insider purchase on record.
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Azoy Alexander | Chief Accounting Officer | Sell 10b5-1 | 2,827 | $30.00 | $84.8K | 39,581 −6.7% of holding | |
| Jaen Juan C. 2 fills | President | Sell 10b5-1 | 20,067 | $28.62 | $574.3K | 822,508 −2.4% of holding | |
| Jaen Juan C. | President | Sell 10b5-1 | 48,502 | $30.05 | $1.5M | 842,307 −5.4% of holding | |
| Jaen Juan C. | President | Sell 10b5-1 | 6,431 | $29.66 | $190.7K | 890,809 −0.7% of holding | |
| Jaen Juan C. 2 fills | President | Sell 10b5-1 | 15,764 | $27.73 | $437.1K | 898,937 −1.7% of holding | |
| Jaen Juan C. | President | Sell 10b5-1 | 9,236 | $27.03 | $249.7K | 913,004 −1% of holding | |
| Azoy Alexander | Chief Accounting Officer | Sell 10b5-1 | 2,562 | $25.77 | $66.0K | 39,581 −6.1% of holding | |
| Goeltz II Robert C. | Chief Financial Officer | Sell 10b5-1 | 7,763 | $25.63 | $199.0K | 84,161 −8.4% of holding | |
| Jaen Juan C. 3 fills | President | Sell 10b5-1 | 31,823 | $21.41 | $681.3K | 924,393 −3.3% of holding | |
| Goeltz II Robert C. | Chief Financial Officer | Sell 10b5-1 | 6,552 | $23.38 | $153.2K | 67,924 −8.8% of holding | |
| Azoy Alexander | Chief Accounting Officer | Sell 10b5-1 | 4,343 | $22.25 | $96.6K | 18,531 −19% of holding | |
| ROSEN TERRY J | Chief Executive Officer | Sell | 25,744 | $22.16 | $570.5K | 2,194,809 −1.2% of holding | |
| Jaen Juan C. | President | Sell | 9,983 | $22.16 | $221.2K | 346,012 −2.8% of holding | |
| Jarrett Jennifer | Chief Operating Officer | Sell | 9,983 | $22.16 | $221.2K | 193,024 −4.9% of holding | |
| Tang Carolyn C. | General Counsel | Sell | 6,810 | $22.16 | $150.9K | 124,734 −5.2% of holding | |
| Goeltz II Robert C. | Chief Financial Officer | Sell | 5,960 | $22.16 | $132.1K | 74,476 −7.4% of holding | |
| Markus Richard | Chief Medical Officer | Sell | 4,494 | $22.16 | $99.6K | 65,647 −6.4% of holding | |
| Azoy Alexander | Chief Accounting Officer | Sell | 2,113 | $22.16 | $46.8K | 22,874 −8.5% of holding | |
| ROSEN TERRY J | Chief Executive Officer | Sell | 28,947 | $21.88 | $633.5K | 2,220,553 −1.3% of holding | |
| Jaen Juan C. | President | Sell | 11,225 | $21.88 | $245.7K | 355,995 −3.1% of holding | |
| Jarrett Jennifer | Chief Operating Officer | Sell | 11,225 | $21.88 | $245.7K | 203,007 −5.2% of holding | |
| Tang Carolyn C. | General Counsel | Sell | 7,658 | $21.88 | $167.6K | 131,544 −5.5% of holding | |
| Goeltz II Robert C. | Chief Financial Officer | Sell | 6,702 | $21.88 | $146.7K | 80,436 −7.7% of holding | |
| Markus Richard | Chief Medical Officer | Sell | 5,052 | $21.88 | $110.6K | 70,141 −6.7% of holding | |
| Azoy Alexander | Chief Accounting Officer | Sell | 2,376 | $21.88 | $52.0K | 24,987 −8.7% of holding | |
| Jaen Juan C. | President | Sell 10b5-1 | 82,997 | $24.71 | $2.1M | 954,063 −8% of holding | |
| Goeltz II Robert C. | Chief Financial Officer | Sell 10b5-1 | 5,000 | $25.00 | $125.0K | 87,138 −5.4% of holding | |
| Azoy Alexander | Chief Accounting Officer | Sell 10b5-1 | 1,900 | $26.00 | $49.4K | 27,363 −6.5% of holding | |
| Jaen Juan C. | President | Sell 10b5-1 | 5,050 | $19.75 | $99.7K | 1,037,060 −0.5% of holding | |
| Jaen Juan C. 2 fills | President | Sell 10b5-1 | 44,950 | $20.31 | $913.0K | 1,049,946 −4.1% of holding | |
| Jarrett Jennifer | Chief Operating Officer | Sell 10b5-1 | 50,291 | $18.97 | $954.1K | 214,232 −19% of holding | |
| Jaen Juan C. | President | Sell 10b5-1 | 4,314 | $20.32 | $87.6K | 1,087,060 −0.4% of holding | |
| Jaen Juan C. 3 fills | President | Sell 10b5-1 | 77,840 | $20.90 | $1.6M | 1,121,539 −6.5% of holding | |
| Jaen Juan C. | President | Sell 10b5-1 | 19,019 | $20.19 | $383.9K | 1,169,214 −1.6% of holding | |
| Goeltz II Robert C. | Chief Financial Officer | Sell 10b5-1 | 5,000 | $20.00 | $100.0K | 92,138 −5.1% of holding | |
| Jarrett Jennifer | Chief Operating Officer | Sell 10b5-1 | 37,792 | $15.05 | $568.6K | 214,232 −15% of holding | |
| Jarrett Jennifer | Chief Operating Officer | Sell 10b5-1 | 12,500 | $14.54 | $181.8K | 214,232 −5.5% of holding | |
| Azoy Alexander | Chief Accounting Officer | Sell 10b5-1 | 2,831 | $13.00 | $36.8K | 27,363 −9.4% of holding |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.